Search

everythinglearnresearchcommunity

for

Search:↓

Both dermatologists and patients in Japan agree that treatment success for alopecia areata is having 20% or less scalp hair loss.

Treating chronic hand eczema costs about the same in statutory and occupational health insurances in Germany, but work-related cases may lead to higher indirect costs due to longer work absences.

Targeting CD200 could be a new treatment for rheumatoid arthritis.

Elderly patients with CCCA were all African American with low vitamin D, but no iron or zinc deficiencies, and no hormonal imbalances compared to younger patients.

Lupus patients in Ghana face healthcare challenges, and the Oyemam Autoimmune Foundation is working to improve awareness and support.

Vaccination is crucial for psoriasis patients on immunosuppressive therapy to manage COVID-19 risks.

New treatments targeting immune pathways show promise for severe hair loss but need more research for safety and effectiveness.

Effective epilepsy management involves accurate diagnosis, understanding seizure types, identifying causes, and choosing the right treatment.

Artesunate is generally safe for severe malaria, but patients should be monitored for delayed anemia after treatment.

Anifrolumab helped some lupus patients reduce steroid use, but safety concerns remain.

Severe alopecia areata greatly impacts quality of life, mental health, and daily activities.

Patients should discuss complementary medicine use with doctors to improve health outcomes.

Atypical symptoms in lupus can indicate different kidney issues.

Cooling the skin before injections reduces pain for patients with hair loss.

Severe pediatric alopecia areata worsens quality of life for patients and families.

A fungus ball in the lung can cause coughing up blood in SLE patients.

Using a call center to collect data in a trial for eye disease in diabetics led to high response rates and very little missing information.

Genotyping for NUDT15 p.Arg139Cys can help predict thiopurine side effects in Japanese IBD patients.

The review concludes that the Ziziphus species, especially jujube, may promote hair growth and have various health benefits, warranting more research.

Targeting the IL-23/IL-17 pathway effectively treats several inflammatory skin diseases.

Adalimumab is the most effective treatment for severe hidradenitis suppurativa, but more research is needed to improve treatment options.

New treatments for a chronic skin condition show promise, but individualized plans are crucial due to varying responses.

Young HS patients often have other physical and mental health issues, and research on HS covers a wide range of topics including genetics, triggers, treatments, and the need for more data.

Most patients successfully switched from the original adalimumab to a biosimilar with few reverting due to reduced effectiveness or side effects.

Psoriasis patients have different skin bacteria, which may cause flare-ups.

Baricitinib helps alopecia areata and may improve psoriasis, but its effect on psoriatic arthritis is unclear.

Baricitinib improves alopecia areata and may help psoriasis but might not be ideal for psoriatic arthritis.

Diabetic patients' stem cells make vascular grafts more prone to clots, but new methods may improve grafts.

Costovertebral arthritis can cause chronic back pain in SLE patients and needs thorough evaluation.

Deuruxolitinib effectively improves hair regrowth in alopecia areata but requires monitoring for side effects.